Frequency of drug use 12 months · Parents who use substances
2 findings from 1 review
Frequency of alcohol misuse 6 months · Parents who use substances
1 finding from 1 review
Intervention not reported
Intervention (no. of studies/participants) · Patients with RRMS Interventions: Azathioprine, daclizumab, fingolimod, glatiramer acetate, Immunoglobulins, interferon beta 1a ‐1b,…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Intervention (no. of studies/participants) · Patients with RRMS Interventions: alemtuzumab, azathriopine, cladribine, dimethylfumarate, fingolimod, glatiramer acetate,…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Intervention (no. of studies and participants) · Patients with RRMS Interventions: Alemtuzumab, azathioprine, cladribine, dimethylfumarate, fingolimod, glatiramer acetate,…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Intervention (no. of studies/participants) · Patients with RRMS Interventions: Alemtuzumab, azathioprine, cladribine, daclizumab, dimethylfumarate, fingolimod, glatiramer acetate,…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Intervention (no. of studies/participants) · Patients with RRMS Interventions: Alemtuzumab, cladribine, daclizumab, dimethylfumarate, fingolimod, glatiramer acetate, interferon…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Depressive symptomatology (lower = less depressive symptomatology): end‐of‐intervention · older people with depression
1 finding from 1 review
Treatment non‐acceptability (higher = greater non‐acceptability): end‐of‐intervention · older people with depression
1 finding from 1 review
Depression remission · older people with depression
1 finding from 1 review
Quality of life or psychological well‐being (higher = higher quality of life or psychological well‐being): end‐of‐intervention · older people with depression
1 finding from 1 review
Anxious symptomatology (lower = less anxious symptomatology): end‐of‐intervention · older people with depression
1 finding from 1 review
Extent of substance use at short‐term · people with substance use (adults, young adults, adolescents)
2 findings from 1 review
Extent of substance use at short‐term · people with substance use (adults, young adults, adolescents)
2 findings from 1 review
Ultrasound maturation (isotonic exercise training versus no intervention) · CKD patients who underwent AVF creation
Upper limb exercise training showed no clear difference in ultrasound maturation (isotonic exercise training versus no… compared with control (no intervention/usual care/isotonic exercise) (low certainty).
1 finding from 1 review
Clinical maturation (isotonic exercise training versus no intervention) · CKD patients who underwent AVF creation
Upper limb exercise training may leads to higher clinical maturation (isotonic exercise training versus no… compared with control (no intervention/usual care/isotonic exercise) (low certainty).
1 finding from 1 review
Intervention not reported
All intervention options · people with first recurrence of glioblastoma Interventions: bevacizumab (BEV), BEV + lomustine (LOM), regorafenib (REG), fotemustine…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
All intervention options · people with first recurrence of glioblastoma Interventions: bevacizumab (BEV), BEV + lomustine (LOM), regorafenib (REG), BEV + irinotecan…
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Number of participants receiving a regular prescription of antipsychotic medication · Residents of nursing homes and other long-term care facilities
1 finding from 1 review
Adverse events · Residents of nursing homes and other long-term care facilities
1 finding from 1 review